Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT06346067
Title A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)
Acronym SEACRAFT-2
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Erasca, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | GBR | AUS

Facility Status City State Zip Country Details
The Melanoma and Skin Care Institute RECRUITING Englewood Colorado 80113 United States Details
Barbara Ann Karmanos Cancer Institute RECRUITING Detroit Michigan 48201 United States Details
Washington University School of Medicine RECRUITING Saint Louis Missouri 63110 United States Details
Cleveland Clinic Foundation RECRUITING Cleveland Ohio 44195 United States Details
SCRI Oncology Partners (formerly Tennessee Oncology) RECRUITING Nashville Tennessee 37203 United States Details
The University of Texas MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
University of Wisconsin RECRUITING Madison Wisconsin 53792 United States Details
Calvary Mater Newcastle RECRUITING Waratah New South Wales 2298 Australia Details
Tasman Health Care RECRUITING Southport Queensland 4215 Australia Details
Sarah Cannon Research Institute - HCA Healthcare RECRUITING City of London London W1G 6AD United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field